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Abstract 
 
In the field of transdermal and topical drug delivery, vesicles have gained high interest 
in the past few decades. Vesicles could be used as a model skin membrane, e.g. stratum 
corneum lipid liposomes (SCLLs), as well as drug delivery carriers, e.g. liposomes and 
niosomes. In the present study, these applications of vesicles were investigated.  
In the first chapter, SCLLs were prepared to serve as a model stratum corneum (SC) 
intercellular lipid to evaluate the effect of chemical penetration enhancers (CPEs) on the barrier 
function of SC lipid. A fluorescent probe; sodium fluorescein (FL) was entrapped in SCLLs 
for investigation of the FL leakage from SCLLs. Also, 1,6-diphenyl-1,3,5-hexatriene (DPH), 
N,N,N-trimethyl-4-(6-phenyl-1,3,5-hexatrien-1-yl)phenyl-ammonium p-toluenesulfonate 
(TMA-DPH) or 8-anilino-1-naphthalenesulfonic acid ammonium salt (ANS) were separately 
entrapped in SCLLs for the measurement of SCLL membrane fluidity. The preliminary study 
was performed using ethanol as a model CPE. The relationship between the conventional 
animal assay (skin permeation/ skin impedance test) on hairless rat skin and the test based on 
SCLLs (FL leakage and SCLL membrane fluidity test) was evaluated. Fair correlations were 
obtained from the increase in enhancement ratio (ER) of caffeine permeation with FL leakage 
and SCLLs membrane fluidity measured using ANS probe with R2 of 0.8882 and 0.8993, 
respectively. FL leakage and SCLLs membrane fluidity test measured using DPH probe were 
also performed with various types and concentrations of well-known CPEs. An effective 
concentration for promoting 10% FL leakage and increase in SCLLs membrane fluidity (EC10, 
leakage and EC10, fluidity) were calculated by interpolation from their concentration profiles. The 
lipophilic CPEs tends to exhibit lower EC10, leakage and EC10, fluidity than hydrophilic CPEs. In 
addition, the relationship between FL leakage and SCLLs membrane fluidity were classified 
into five categories depending on the action on SCLLs. This method using SCLL as a model 
SC intercellular lipid could be utilized in investigating the effects of CPE on SC as an 
alternative high-throughput screening (HTS) technique in contrast to conventional animal 
testing.  
In the second chapter, components of vesicles having high skin penetration-enhancing 
effect was selected to formulate new penetration-enhancing vesicles. The screening of 
phospholipids and non-ionic surfactants was performed using diffusion cell array system and 
abdominal skin of hairless rat. Caffeine was used as a hydrophilic model drug. The results 
showed a significant increase in ER from 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), 
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1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol, sodium salt (DPPG), Brij 30, Span 20, Tween 
20, Tween 40 and Tween 60, compared to the control solution. The liposomes and niosomes 
prepared from varying compositions influenced particle size, transition temperature, 
entrapment efficiency and zeta potential. The vesicles exhibiting high ER were DPPG, 1,2-
dilauroyl-sn-glycero-3-phosphocholine (DLPC), 1,2-dimyristoyl-sn-glycero-3-phospho-
choline (DMPC) liposomes and Span 20, Tween 85 niosomes. In addition, two kinds of 
experiments were done to clarify the possible mechanism of liposomes as follows: the excised 
skin was pretreated for 1 h with caffeine-free phospholipid dispersions and liposomes, and 
caffeine solution was added to determine its skin permeation. Separately, caffeine permeation 
experiments were done using physical mixture of blank liposomes and caffeine solution 
(caffeine-spiked liposomes) and caffeine-entrapped liposomes (caffeine was entrapped only in 
liposomes). As a result, DPPG was found to be a promising phospholipid candidate to develop 
liposome formulations since it could significantly enhance the skin permeation of caffeine as 
in the pretreatment experiments.  In addition, DPPG liposomes could carry both non-entrapped 
and entrapped caffeine through the skin. Thus, selecting the compositions of liposomes and 
niosomes is a crucial factor to consider in improving the skin penetration of drugs from the 
drug delivery carriers. 
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General Introduction 
 
Skin is the largest human organ acting as a barrier against exogenous materials as well 
as controlling the homeostasis1). Skin has been recognized as a site for topical application of 
drugs to expect local and/or systemic therapeutic effects with its non-invasiveness, control of 
release property, avoidance of gastrointestinal and first pass metabolism, and reduction of side 
effects associated with high oral dose and gastrointestinal distress2,3). 
Due to the barrier properties of the skin, only low-dose and potent lipophilic drugs can 
be optimally delivered at therapeutic rates by passive diffusion3). Thus, many approaches to 
overcome the barrier function of the skin were introduced in order to increase drug delivery 
into and through the skin such as prodrug approach, application of chemical penetration 
enhancers (CPEs), use of physical means such as iontophoresis, electroporation and 
microneedle, and drug delivery carrier approaches4-6). Among them, the use of vesicles such as 
liposomes and niosomes is one of the approaches that have been extensively investigated to 
deliver drugs through skin. Vesicles can be defined as highly ordered assemblies of one or 
several concentric bilayers spontaneously formed when amphiphilic building blocks are 
surrounded with water7). 
In the field of topical and transdermal drug delivery, several kinds of vesicles can be 
utilized as model membranes to mimic stratum corneum (SC) lipids as well as drug carriers to 
enhance delivery of drugs into and through the skin. 
The usefulness of vesicles as model SC membrane has been already reported. 
Liposomal vesicles can be used as an alternative tool representing human and animal skin 
models, since liposomes show a multiple bilayered organization similar to the human SC 
intercellular lipid domains. Conventionally, the investigation of the skin penetration-
enhancement effect of chemicals relies on the skin permeation study and/or skin impedance 
test using human or animal skin as test membranes8,9). These methods are time consuming, 
expensive and associated with ethical issues. Therefore, liposome, as a SC lipid alternative, has 
been used to investigate the action of CPEs10-12). 
 The first chapter of the present study focused on the development of high-throughput 
screening (HTS) technique based on the SC lipid liposomes (SCLL), which were prepared 
using similar lipid compositions to SC lipid, for testing various types and concentrations of 
CPEs. This study was based on the ability of CPEs to promote the leakage and fluidity of the 
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SCLL due to the disruption on the lipid bilayers structure.  The suitability of using liposomes 
as model SC membrane was evaluated by comparing with a conventional evaluation method 
for skin penetration-enhancing effects, i.e., skin permeation experiment and skin impedance 
determination. 
The second chapter of the present study was related to the usefulness of several vesicles 
as a drug carrier for topical and transdermal drug delivery, since vesicles provide various 
advantages; they can entrap both hydrophilic and lipophilic molecules, protect the encapsulated 
drug from chemical degradation, and control the drug release while having high skin 
permeability enhancement13-15). 
Several mechanisms on the skin penetration enhancement by vesicular carriers have 
been reported including intact vesicular skin penetration, penetration-enhancing effect, 
adsorption effect and penetration of liposomes through the transappendageal route15. 
Interestingly, the proposed mechanisms for skin penetration-enhancement effect of vesicles are 
related to the penetration of vesicle lipids into the SC and then destabilization, followed by 
fusion or mixing with the intercellular lipid matrix to loosen the packed intercellular lipid 
structure with subsequent increased skin partitioning of the drugs16).  
Since the composition of vesicles can also affect to their skin penetration-enhancing 
effects of drugs, the selection of the candidate amphiphilic compositions (phospholipids and 
non-ionic surfactants) is important for obtaining a high skin penetration-enhancing effect of 
the carriers. Hence, in the second chapter, a novel approach to formulate penetration-
enhancement vesicles was developed. This approach is based on the selection of the vesicular 
carrier composition by in vitro skin permeation screening to assess the suitable compositions 
with high skin penetration-enhancement effect for a model hydrophilic drug, caffeine. 
Liposomes and niosomes were prepared and determined for the skin penetration-enhancing 
property.  The obtained results were compared to those by aqueous dispersion of their 
phospholipids/non-ionic surfactants. In addition, the possible mechanisms for the high skin 
penetration-enhancing effect from vesicles were investigated. 
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Chapter 1  
 
Potential of stratum corneum lipid liposome as a tool for screening of chemical 
penetration enhancers 
 
1.1.  Introduction 
 
Skin is of considerable interest as an administration route for drugs with both local and 
systemic effects. However, the main obstacle for drugs to pass through the skin and exert their 
pharmacological activities is the intrinsic barrier function of the SC. The SC is the uppermost 
layer of the skin consisting of keratin-filled corneocytes and intercellular lipids1,17). Generally, 
drugs in vehicles applied topically onto the skin firstly distribute into the SC and then diffuse 
mainly through the intercellular lipid domain in the SC18). Because the intercellular lipids 
organize into multi-lamellar complexes filling the intercellular spaces to provide a strong 
barrier against the entry of the exogenous drugs19), approaches to overcome the skin barrier 
function have been investigated extensively to improve the skin permeability of drugs. 
Use of CPEs is a conventional and effective approach to overcome the high barrier 
function of the SC. They promote the skin permeation of drugs by reducing skin barrier 
resistance20). CPEs may disrupt intercellular lipids, or interact with intracellular proteins or 
with both regions in the SC10). Conventional CPEs have been screened using skin permeation 
experiments to determine the cumulative amount of skin permeation, flux and permeability 
coefficient of drugs in the presence and absence of CPEs9). However, these conventional 
approaches are time-consuming, complicated and resource expensive. These methods are not 
practical for HTS with various types and concentrations of CPEs as part of their discovery and 
development. In addition, increasing awareness of animal welfare issues nowadays has brought 
about a reduction in animal-based experiments, especially in the cosmetics industries. This 
situation gives rise to a need to develop an effective replacement approach that can provide 
HTS for effective CPEs as well as avoid the use of experimental animals. 
SCLLs consist of a lipid mixture similar to SC multi-lamellar lipid bilayers that are 
composed of ceramides, cholesterol, cholesterol esters and fatty acids19,21). SCLLs have been 
used as an SC intercellular lipid mimicking model to investigate the effect of agents on the skin 
permeability and the mechanism of enhanced skin delivery22,23). One of the determination 
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procedures is based on the change in transition temperature (Tm) of SCLLs due to the chemicals 
determined by differential scanning calorimetry (DSC)22). However, this technique is also time-
consuming, unable to simultaneously determine various samples and difficult to obtain 
quantitative data. SCLLs containing entrapped marker(s) (e.g. glucose, mannitol and calcein) 
have been applied to determine the release rate of the markers12,22,24,25). In addition, labeled 
fluorescent probes are also used to measure the fluidizing effect of CPEs on SCLLs26). 
However, these methods are still not appropriate for HTS of CPEs, because of the complicated 
analytical methods and rather long experimental time.  
Thus, the aim of the present chapter was to establish a simple, quantitative, fast and 
practical approach for HTS of potential CPEs.  Ethanol was used as a model CPE to firstly 
investigate the potential of SCLLs based on the HTS methodology, because it is well- known 
and is already used to increase the skin penetration of various drugs such as hydrocortisone, 5-
fluorouracil and estradiol27-29) .  SCLLs entrapped of a hydrophilic fluorescent probe, sodium 
fluorescein (FL) and incubated with three fluorescent probes with different lipophilicities were 
used to observe SCLL leakage and fluidity, respectively, and compared with conventional in 
vitro skin permeation test as well as skin impedance test to determine the effectiveness of this 
HTS technology. Moreover, various types of well- known CPEs with different concentrations 
were determined for their effects on SCLL leakage and fluidity as well as categorized according 
to their concentration profiles and the mechanism of those CPEs action on SC lipids was 
proposed.  
 
1.2.  Materials and Methods 
 
1.2.1. Materials 
FL, lignoceric acid, palmitic acid, boric acid, potassium chloride, sodium hydroxide, 
chloroform, methanol, ethanol, n-propanol, Transcutol® (diethylene glycol monoethyl ether), 
dimethyl sulfoxide, oleic acid, ethyl oleate, sodium dodecyl sulfate, Brij® 58 and 1-methyl-2-
pyrrolidone were purchased from Wako Pure Chemicals Industries, Ltd. (Osaka, Japan). 
Cholesterol, cholesteryl sulfate, octacosanoic acid, 1,6-diphenyl-1,3,5-hexatriene (DPH), 
N,N,N-trimethyl-4-(6-phenyl-1,3,5-hexatrien-1-yl)phenyl-ammonium p-toluenesulfonate 
(TMA-DPH), 8-anilino-1-naphthalenesulfonic acid ammonium salt (ANS) and Pluronic® F-
127, were obtained from Sigma-Aldrich (St. Louis, MO, USA). CER[NP] (N-(octadecanoyl)-
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phytosphingosine) and CER[AP] (N-(α-hydroxyoctadecanoyl)-phytosphingosine) were 
obtained from Evonik Industries AG (Essen, Germany). Sodium decanoate, 1,8-cineol, lauryl 
alcohol, cetylpyridinium chloride, polyoxyethylene sorbitan fatty acid esters (Tween 20, 40, 
60, 80, 85) and sorbitan fatty acid esters (Span 20, 40, 60, 80) were obtained from Tokyo 
Chemical Industry Co., Ltd. (Tokyo, Japan). Propylene glycol, polyethylene glycol (PEG) 400 
and benzyl alcohol were obtained from Kanto Chemical Co., Inc. (Tokyo, Japan). Sefsol 218 
(propylene glycol monocaprylate) was a kind gift from Nikko Chemicals Co., Ltd. (Tokyo, 
Japan). Pluronic® P-84 was supplied by Adeka Corporation (Tokyo, Japan) and l-menthol was 
obtained from Fisher Scientific Japan (Tokyo, Japan). These reagents were used without further 
purification. 
 
1.2.2. Experimental animals 
Male WBN/ILA-Ht hairless rats, weighing between 200 and 260 g, were obtained from 
the Life Science Research Center, Josai University (Saitama, Japan) and Ishikawa 
Experimental Animal Laboratories (Saitama, Japan). Rats were bred in a room maintained at 
25 ± 2°C, in which the on and off times for the lighting were 07:00 and 19:00, respectively. 
Animals had free access to water and food (MF, Oriental Yeast Co., Ltd., Tokyo, Japan). 
All breeding procedures and experiments on the animals were performed in accordance 
with the guidelines of the Animal Experiment Committee of Josai University (Sakado, Saitama, 
Japan) 
 
1.2.3. Measurement of skin impedance reduction rate 
The mixture of three types of anesthesia (medetomidine, 0.375 mg/kg; butorphanol, 2.5 
mg/kg; and midazolam, 2 mg/kg) was injected intraperitoneally into hairless rats. Hairs were 
removed from the back under anesthesia. The treated back skin was excised, and subcutaneous 
fat was removed carefully using scissors. The skin was mounted with the SC side up on a 
square-type diffusion cell with an effective area of 19.5 cm2 and a receiver volume of 45 mL. 
Eight donor cells with an effective diffusion area of 0.795 cm2 were glued with cyanoacrylate 
bond (Aron Alpha®, Konishi Co. Ltd., Osaka, Japan) onto the skin as shown in Fig. 1-1. Then, 
1.0 and 45 mL physiological saline were added to the donor and receiver cells, respectively, to 
hydrate the skin. Skin impedance was then determined using an impedance meter (Asahi 
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Techno Lab., Ltd., Yokohama, Japan) 1 h after hydration. Thereafter, the physiological saline 
was removed from the donor cell and 1.0 mL of different concentrations of ethanol was applied 
for 1 h. At the end of the experiment, the donor solution was removed, the same volume of 
fresh saline was added and skin impedance was determined again. Reduction in the skin 
impedance (%) was calculated from the following equation. 
 
Reduction in the skin impedance (%) = (1 −
skin impedance after applied ethanol solution
skin impedance after hydration
) x100     (1) 
 
 
Fig. 1-1. Set-up of large-sized cell for skin impedance measurement. 
 
1.2.4. In vitro skin permeation experiments 
Excised abdominal skin from hairless rat was mounted in a vertical-type Franz diffusion 
cell (receiver cell volume 6.0 mL and effective permeation area 1.77 cm2) with the SC side 
facing the donor cells and the dermal side facing the receiver cell. The receiver cell was filled 
with 6.0 mL phosphate-buffered saline pH 7.4 (PBS). PBS was also added to the donor cells 
for 1 h for skin hydration. Then, 0.5 mL of 2 mg/mL caffeine solution in 0, 10, 20, 30, 40, 50, 
75 or 100% ethanol in PBS were applied to determine the skin permeation of caffeine at 32°C 
over 8 h while the receiver solution was agitated at 500 rpm using a magnetic stirrer. At 
predetermined times, 0.5 mL aliquots were collected and the same volume of PBS was added 
to keep the volume constant. 
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1.2.5. Determination of caffeine permeation 
The concentration of caffeine was determined using a high-performance liquid 
chromatography (HPLC) system (Prominence, Shimadzu Corporation, Kyoto, Japan) equipped 
with a UV detector (SPD-M20A, Shimadzu Corporation). Briefly, the receiving solutions were 
mixed with the same volume of methanol. After centrifugation at 21,500 × g at 4°C for 5 min, 
the resulting supernatant (20 µL) was injected directly into the HPLC system. Chromatographic 
separation was performed at 40°C using an Inertsil ODS-3, 5 μm in diameter, 4.6 mm I.D. x 
150 mm (GL Sciences Inc., Tokyo, Japan). The mobile phase was 0.1% phosphoric 
acid:methanol 7:3 v/v and the flow rate was 1.0 mL/min. UV absorbance detection was 
performed at 280 nm. The increase in the skin penetration-enhancement ratio (ER) after 8 h-
permeation experiment was calculated using the following equation. 
 
 Increase in ER = (
𝑄𝑠𝑎𝑚𝑝𝑙𝑒−𝑄𝑐𝑜𝑛𝑡𝑟𝑜𝑙 
𝑄𝑐𝑜𝑛𝑡𝑟𝑜𝑙
)     (2) 
 
where Qsample and Qcontrol are the cumulative amount of caffeine permeated per unit area of skin 
over 8 h from different concentrations of ethanol and PBS, respectively. 
 
1.2.6. Preparation of SCLLs 
SCLLs were prepared using the thin film hydration method reported by Hatfield and 
Fung (1999)30) with a slight modification. Total lipids (5.5 mg/mL), which include 33% 
CER[NP], 22% CER[AP], 25% cholesterol, 5% cholesteryl sulfate, 7.5% lignoceric acid, 
3.75% palmitic acid, and 3.75% octacosanoic acid were first dissolved in chloroform:methanol 
(2:1) in a round-bottomed flask. The solvent was then evaporated at 60°C under reduced 
pressure using a rotary evaporator until a thin film was obtained on the wall of the flask. The 
flask was then purged with N2 gas and allowed to stand overnight to remove any traces of 
organic solvents. Next, the lipid film was annealed in a water bath at 90°C for 30 min. FL in 
0.1 M borate buffer pH 9.0 (2.5 mg/mL) for FL-SCLLs or plain buffer for blank-SCLLs was 
used to hydrate the lipid film. The resulting SCLL suspension was then sonicated using a probe 
sonicator (VCX-750, Sonics & Materials Inc., Newtown, CT, USA) at an amplitude of 20% 
for 30 s. A freeze-thaw process was performed by immersing the flask in liquid N2 and in a 
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water bath at 90°C, each for 3 min in 4 cycles. The obtained liposomes were further extruded 
using an extruder (LipexTM, Northern Lipids Inc., Burnaby, BC, Canada) with a membrane 
filter with pore sizes of 400, 200 and 100 nm (Nucleopore® track-etched membranes, GE 
Healthcare Japan, Tokyo, Japan), twice for each size of filter.  
After preparation of FL-SCLLs, excess FL was removed by ultra-centrifugation 
(Hitachi CS100GXL, Hitachi Koki Co., Ltd., Tokyo, Japan) at 289,000 × g, 4°C twice for 15 
min, twice for 10 min and 5 times for 5 min. At each centrifugation process, the supernatant 
was removed and the same volume of 0.1 M borate buffer was added and mixed. 
 
1.2.7. Determination of FL leakage from SCLLs 
FL-SCLLs were mixed 5 times by pipetting with different types and concentrations of 
CPEs solution in borate buffer, as shown in Table 1-1, at a ratio of FL-SCLLs: CPEs solution 
1:9 v/v. However, 3% ethanol in borate buffer was used as solubilizing medium for oleic acid, 
ethyl oleate, Sefsol 218, lauryl alcohol, l-menthol and 1,8-cineol. Each sample was allowed to 
stand for 30 min at room temperature and immediately ultracentrifuged (Hitachi CS100GXL, 
Hitachi Koki Co., Ltd., Tokyo, Japan) at 289,000 × g, 4°C for 5 min. The supernatant was 
collected to determine the amount of FL that leaked from FL-SCLLs after mixing with CPEs 
solution (FL leakage), using a microplate reader (Spectra Max® M2e, Molecular Devices, LLC., 
Sunnyvale, CA, USA) at excitation and emission wavelengths of 485 and 535 nm, respectively. 
This study was also performed using 75% ethanol and 0.1 M borate buffer to represent total 
and background FL leakage, respectively. A concentration of ethanol at 75% was found to 
totally disrupt the FL-SCLLs as no evidence of SCLL pellet precipitation was observed after 
the ultracentrifugation process.  The calculation of FL leakage (%) is shown as follows: 
 
FL leakage (%) = (
𝐹𝐿𝑠𝑎𝑚𝑝𝑙𝑒−𝐹𝐿𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑
𝐹𝐿𝑡𝑜𝑡𝑎𝑙−𝐹𝐿𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑
)  x 100        (3) 
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Table 1-1. List of CPEs and their concentrations tested in this study 
 
  
Group of enhancers Enhancers Concentration (%) 
Anionic surfactant Sodium dodecyl sulfate  0.01, 0.05, 0.1, 1.0, 2.5, 5.0 
Cationic surfactant Cetylpyridinium chloride  0.01, 0.05, 0.1, 1.0, 2.5, 5.0 
Nonionic surfactant 
  
Polysorbates Tween 20, 40, 60, 80, 85  0.01, 0.05, 0.1, 1.0, 2.5, 5.0 
Sorbitans Span 20, 40, 60, 80 0.01, 0.05, 0.1, 1.0, 2.5, 5.0 
Brij Brij 58 0.01, 0.05, 0.1, 1.0, 2.5, 5.0 
Pluronic Pluronic P-84, F-127 0.01, 0.05, 0.1, 1.0, 2.5, 5.0 
Urea and its derivatives Urea  5, 10, 20, 30, 40, 50 
Glycols PEG 400, Propylene glycol 5, 10, 20, 30, 40, 50, 75 
 
Transcutol 5, 10, 20, 30, 40, 50, 75 
Short chain alcohols Ethanol, n-Propanol 5, 10, 20, 30, 40, 50, 75 
Aromatic ring alcohols Benzyl alcohol 2.5, 5, 10  
Fatty acids Sodium decanoate 
Oleic acid, Ethyl oleate 
1, 5, 10, 20, 30 
0.01, 0.05, 0.1  
Polyol fatty acid esters Sefsol 218 0.01, 0.05, 0.1, 1, 2.5, 5  
Fatty alcohols Lauryl alcohol 0.01, 0.05, 0.1 
Sulfoxides Dimethyl sulfoxide 5, 10, 20, 30, 40, 50, 75 
Pyrrolidones 1-Methyl-2-pyrrolidone 1, 5, 10, 20 
Terpenes l-Menthol, 1,8-Cineol 0.01, 0.05, 0.1, 1.0 
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1.2.8. Measurement of SCLLs membrane fluidity 
The fluidity of the SCLL membranes was determined according to the method of Tan 
et al. (2016) with a slight modification31). The blank SCLLs and 2 × 10-5 M DPH solution in 
PBS (25:75 µL) were firstly mixed in a 96-well plate and then subjected to shaking in an orbital 
shaker (IKA® MS1 Minishaker, Sigma-Aldrich, Willmington, NC, USA) at 500 rpm for 30 
min in the absence of light. Next, different concentrations of CPEs in 0.1 M borate buffer (100 
µL) were added and shaken in the same conditions. The fluorescence polarization (Pf) was 
measured at 25°C using a microplate reader (Spectra Max® M5e, Molecular Devices, LLC., 
Sunnyvale, CA, USA) at excitation and emission wavelengths of 358 nm and 425 nm, 
respectively. The Pf value was calculated according to the following equation: 
  
Pf = (
𝐼||−𝐺𝐼⊥
𝐼||+𝐺𝐼⊥
)      (4) 
 
where I|| and I⊥ are the fluorescence intensities of the emitted light polarized parallel and 
perpendicular to the excited vertical light, respectively. G is an instrumental correction factor 
grating correction coefficient32,33). 
In addition, the increase in SCLL membrane fluidity was calculated as follows: 
 
Increase in SCLL fluidity = (
𝑃𝑓,𝑐𝑜𝑛𝑡𝑟𝑜𝑙−𝑃𝑓,𝑠𝑎𝑚𝑝𝑙𝑒
𝑃𝑓,𝑐𝑜𝑛𝑡𝑟𝑜𝑙
)  x 100     (5) 
 
where Pf,control was obtained from DPH-SCLL incubated with plain 0.1 M borate buffer. 
 
For determination of the effect of ethanol concentrations on SCLL fluidity, additional 
two fluorescent probes, TMA-DPH and ANS, at concentrations of 1 × 10-5 and 6 × 10-3 M, 
respectively, were incubated with blank SCLL in the same procedure as the DPH probe. The 
determination of SCLL fluidity was performed on excitation and emission wavelengths of 365 
nm and 430 nm for TMA-DPH, and 337 nm and 480 nm for ANS. 
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1.2.9. Calculation of effective concentration for promoting 10% FL leakage (EC10, leakage) and 
10% increase in SCLL fluidity (EC10, fluidity) of each CPE 
EC10, leakage and EC10, fluidity of each CPE was calculated by interpolation from the FL-
leakage or SCLL fluidity-concentration profile to estimate the effectiveness of each CPE to act 
on the SCLLs. In this study, 10% response was selected because most CPEs, within the tested 
concentrations range, could promote the FL leakage as well as the SCLL fluidity. The 
relationship between EC10, leakage or EC10, fluidity and log Ko/w, obtained from ChemBioDraw Ultra 
12.0 software, of each CPE as well as the hydrophile-lipophile balance (HLB) of surfactants 
was also investigated. 
 
1.2.10. Statistics 
Data were expressed as the mean ± standard error (S.E.). The differences among the 
obtained data were analyzed using unpaired t-test. The differences were considered significant 
when p < 0.05. 
 
1.3. Results  
 
1.3.1. Effect of ethanol on in vitro skin permeation of caffeine 
In the present study, caffeine was selected as a hydrophilic model drug to evaluate the 
relationship between its skin permeation rate and the effect of different concentrations of 
ethanol on the SC lipid disruption. Figure 1-2 shows the cumulative amounts of caffeine that 
permeated through the excised hairless rat skin. Typical in vitro skin permeation profiles of 
caffeine (lag time and following almost steady-state profiles) were observed in all cases when 
using 0–100% ethanol as in the donor solution. Figure 1-3 illustrates the relationship between 
the increase in ER and the ethanol concentration in the donor solution. Figures 1-2 and 1-3 
show that the skin permeation of caffeine was strongly dependent on the ethanol concentration 
in the caffeine solution. When the ethanol concentration increased from 0% to 50%, the 
caffeine flux through skin also increased. However, at 100% ethanol, caffeine permeation was 
rather decreased compared with the samples with 50% and 75% ethanol. The maximum skin 
permeation of caffeine was observed with 75% ethanol. The flux, permeability coefficient and 
-14- 
 
skin penetration-enhancement ratio (ER) of caffeine obtained from different concentrations of 
ethanol are also summarized in Table 1-2. 
 
Fig. 1-2. Time course of cumulative amount of caffeine permeated through full-thickness 
hairless rat skin after application with different concentrations of ethanol. Each value represents 
the mean ± S.E. (n = 3–5). 
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Fig. 1-3. Effect of ethanol concentration on the increase in ER of caffeine that permeated 
through full-thickness hairless rat skin over 8 h. Each value represents the mean ± S.E.                      
(n = 3–5). 
 
Table 1-2. Flux, permeability coefficient and ER of caffeine that permeated through full-
thickness hairless rat skin from different concentrations of ethanol 
Formulation 
 
Flux  
(µg/cm2/h) 
Permeability coefficient  
(x10-7 cm/s) 
Enhancement ratio 
(ER) 
0% ethanol 0.80 ± 0.18 1.12 ± 0.25 1.00 ± 0.22 
10% ethanol 0.80 ± 0.15 1.11 ± 0.20 1.07 ± 0.19 
20% ethanol 1.29 ± 0.27 1.79 ± 0.37 1.60 ± 0.32 
30% ethanol 1.59 ± 0.26 2.21 ± 0.36 2.02 ± 0.34 
40% ethanol 2.29 ± 0.12 3.18 ± 0.17 2.82 ± 0.15 
50% ethanol 3.47 ± 0.36 4.81 ± 0.50 4.33 ± 0.52 
75% ethanol 3.38 ± 0.24 4.69 ± 0.34 4.85 ± 0.19 
100% ethanol 3.35 ± 0.37 4.65 ± 0.52 4.26 ± 0.47 
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1.3.2. Effect of ethanol on the skin impedance 
Skin impedance has been used as an index of the skin permeation rate of drugs, 
especially of hydrophilic drugs, because the decrease in skin impedance is related to decreased 
barrier function of the skin. Therefore, skin impedance after pretreatment with different 
concentrations of ethanol was determined. Figure 1-4 shows the decrease in skin impedance 
with different concentrations of ethanol on the excised back skin of hairless rats. Ethanol 
treatment changed the skin impedance even at a low concentration. Ethanol solution at a 
concentration of 5% reduced skin impedance by about 30%, and 20–100% ethanol could 
reduce skin impedance about 75–80%. 
 
Fig. 1-4. Effect of different concentrations of ethanol on the percentage of reduction in skin 
impedance. Each value represents the mean ± S.E. (n = 3–5). The excised back skin from 
hairless rat was used. 
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1.3.3. SCLLs characteristics 
Table 1-3 summarizes the characteristics of blank SCLLs and FL-SCLLs prepared in 
the present study. The vesicle size and distribution of FL-SCLLs were a little larger but 
narrower, respectively, than the blank SCLLs, indicating that the vesicle dispersion was 
homogeneous. Both the liposome formulations showed highly negative surface charge of -87.0 
± 2.3 and -99.6 ± 3.3 mV, respectively, because of the ionized fraction of fatty acids at pH 9.0. 
The presence of FL anions inside the SCLLs leads to higher negative surface charge. The zeta 
potential of both SCLL formulations indicated high electrostatic repulsion among the particles 
and excellent kinetic stability34). The entrapment of FL inside SCLLs was 1.78 ± 0.04%. 
 
Table 1-3. Characteristics of blank SCLLs and FL entrapped in SCLLs (FL-SCLLs) 
 Blank SCLLs FL-SCLLs 
Size (nm)  221.1 ± 8.6 282.8 ± 3.2 
Polydispersity index 0.556 ± 0.017 0.215 ± 0.014 
Zeta potential (mV) -87.0 ± 2.3 -99.6 ± 3.3 
Entrapment (%) - 1.78 ± 0.04 
 
1.3.4. Effect of ethanol on the FL leakage from SCLLs 
Next, the effect of different concentrations of ethanol was tested on the disruption of 
SCLLs. Figure 1-5 shows the relation between the FL leakage (%) and ethanol concentration. 
As the ethanol concentration increased, FL leakage also increased in a concentration-dependent 
manner. At low ethanol concentrations (0–5% ethanol), no significant promotion was observed 
in FL leakage compared with the control (0.1 M borate buffer). At higher concentrations of 
ethanol, on the other hand, FL leakage increased proportionally with the concentration. 
However, no more FL leakage was observed at more than 50% ethanol. 
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Fig. 1-5. Effect of different concentrations of ethanol on the FL leakage from SCLLs. Each 
value represents the mean ± S.E. (n = 3). 
 
1.3.5. Effect of ethanol on membrane fluidity of SCLLs 
Figure 1-6 shows the membrane fluidity of blank SCLLs incubated with fluorescent 
probes with different lipophilicities. The results with DPH and TMA-DPH as fluorescent 
probes showed relatively low membrane fluidity. The maximum increase was observed at 
100% ethanol, which provided 37.8% and 17.9% increase in SCLL fluidity for DPH and TMA-
DPH, respectively. High membrane fluidity was observed when using ANS probe at low 
concentrations of ethanol (0-20% ethanol). 
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Fig. 1-6. Effect of different concentrations of ethanol on the percentage of increase in SCLL 
fluidity using three fluorescent probes, DPH, TMA-DPH and ANS. Each value represents the 
mean ± S.E. (n = 3). 
 
1.3.6. Relationship between FL leakage and increase in ER 
SCLLs were used as an SC lipid model to investigate the enhancing effect of ethanol 
on the skin permeation of caffeine. The correlation was evaluated between the present SCLL-
based HTS data and the conventional skin penetration-enhancing profiles of caffeine. Figure 
1-7a shows the relationship between FL leakage (%) from SCLLs (X-axis) and the increase in 
ER of the cumulative amount of caffeine permeated through skin over 8 h (Y-axis). The 
coefficient of determination (R2) of this relationship was 0.888. The obtained profile was 
concave relative to the Y-axis, indicating that ethanol more markedly affected the SCLL 
disruption than the skin permeation of caffeine, especially at low concentrations of ethanol (0-
20% ethanol). Almost linear relationship could be observed at higher concentrations of ethanol. 
The semi-log plot, as shown in Fig. 1-7b, shows a very high R2 of 0.974. 
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Fig. 1-7. The relationship between FL leakage and increase in ER (a); and log ER (b) of caffeine 
permeated over 8 h from each concentration of ethanol solution. Each value represents the 
mean ± S.E. (n = 3–5). 
 
1.3.7. Relationship between SCLLs membrane fluidity and increase in ER 
Figure 1-8a shows a relationship between SCLL membrane fluidity and the increase in 
the ER. The data from 100% ethanol were not included in this correlation, because the reduction 
in the ER might be exceptional, with such a high concentration of ethanol having a reversed 
effect on the skin permeation of caffeine. The linear relationship could be obtained in SCLL 
membrane fluidity measured using the ANS probe with a R2 of 0.899, whereas DPH and TMA-
DPH showed poorer correlations (R2 of DPH and TMA-DPH; 0.638 and 0.748, respectively). 
A higher correlation in the data using ANS probe was obtained in the semi-log plot as shown 
in Fig. 1-8b, similar to Fig. 1-7b. 
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Fig. 1-8. The relationship between percentage of increase in SCLL fluidity using various 
fluorescent probes and increase in ER (a) and log ER (b) of caffeine permeated over 8 h from 
each concentration of ethanol solution. Each value represents the mean ± S.E. (n = 3–5). The 
data from 100% ethanol was excluded in this figure.  
 
1.3.8. Relationship between reduction in skin impedance and increase in ER 
Figure 1-9 shows a relation between reduction in skin impedance and increase in ER. 
No good relationships were observed; the R2 was 0.456 between the increase in ER at 8 h and 
skin impedance reduction, although such skin impedance was reported to be correlated with 
many skin permeation data of drugs. 
 
 
ANS
y = 0.0562x - 0.379
R² = 0.8993
TMA-DPH
y = 0.660x + 0.710
R² = 0.7477
DPH
y = 0.360x + 0.405
R² = 0.6382
0
1
2
3
4
5
0 20 40 60 80 100
In
cr
ea
se
 i
n
 E
R
o
f 
ca
ff
ei
n
e 
p
er
m
ea
ti
o
n
Increase in SCLL fluidity (%)
ANS
y = 0.011x - 0.042
R² = 0.9517
TMA-DPH
y = 5.662x - 0.553
R² = 0.6248
DPH
y = 9.285x + 0.180
R² = 0.5855
0
0.2
0.4
0.6
0.8
0 20 40 60 80 100
L
o
g
 E
R
o
f 
ca
ff
ei
n
e 
p
er
m
ea
ti
o
n
Increase in SCLL fluidity (%)
a) b) 
-22- 
 
 
Fig. 1-9. The relationship between reduction in skin impedance and increase in ER (a) and log 
ER (b) of caffeine permeated over 8 h from each concentration of ethanol solution. Each value 
represents the mean ± S.E. (n = 3–5). 
 
1.3.9. HTS of various types and concentrations of CPEs on FL leakage from SCLLs 
FL leakage from SCLLs with the addition of different types of CPEs is shown as a 
function of their concentrations in Fig. 1-10. For lipophilic and amphiphilic CPEs, lower 
concentrations were used for evaluation compared with hydrophilic CPEs, as shown in Fig. 1-
10a and b, respectively, because of their limited solubility in 0.1 M borate buffer, which was 
used as a dispersion medium for SCLLs. Most CPEs promoted FL leakage from SCLLs in a 
concentration-dependent manner except for ethyl oleate and cetylpyridinium chloride, which 
had no promoting effect on the FL leakage. The concentration profiles of FL leakage from 
different CPEs could be classified into two types, as shown in Fig. 1-11. Type I (Fig. 1-11a) 
showed a linear relationship between the FL leakage and CPE concentration, whereas type II 
(Fig. 1-11b) showed a concave downward profile, which indicated the limit level for the 
disruption of SCLLs. In both types, the author sometimes observed an intercept of the profile, 
in which the FL leakage was not promoted at lower concentrations than the X-intercept. 
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Fig. 1-10. Relationship between FL leakage from SCLLs and CPE concentration; (a) lipophilic 
and amphiphilic CPEs, (b) hydrophilic CPEs. Each value represents the mean ± S.E. (n = 3). 
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Fig. 1-11. Schematic diagram of the relationship between FL leakage and CPE concentration; 
(a) linear relationship (with intercept), (b) concave downward relationship (with intercept). 
 
The EC10, leakage of each CPE is shown in Table 1-4, lipophilic CPEs were observed to 
provide lower EC10, leakage than hydrophilic CPEs, as shown in the plots between log Ko/w and 
EC10, leakage (Fig. 1-12a). In addition, when comparing amphiphilic CPEs, the more hydrophilic 
surfactants showing higher HLB tended to provide lower EC10, leakage (Fig.1-12b). 
 
Fig. 1-12. Relationship between EC10, leakage and log Ko/w (a) and HLB (b) of CPEs.  Each plot 
represents a single CPE. 
 
0
5
10
15
20
25
30
35
-5 0 5 10
E
C
1
0
, 
L
e
a
k
a
g
e
Log Ko/w of CPEs
a)
0
1
2
3
4
5
0 5 10 15 20 25
E
C
1
0
, 
L
e
a
k
a
g
e
HLB of surfactants
b)
Concentration of CPEs (%) 
F
L
 l
ea
k
a
g
e 
/ 
S
C
L
L
 f
lu
id
it
y
 (
%
) 
 
Type II with intercept 
Type II 
Concentration of CPEs (%) 
F
L
 l
ea
k
a
g
e 
/ 
S
C
L
L
 f
lu
id
it
y
 (
%
) 
 
a) b) 
-25- 
 
Table 1-4. EC10 value calculated from FL leakage and SCLL fluidity-concentration profile 
CPEs EC10 (mean ± S.E.) 
FL leakage SCLL fluidity  
Lauryl alcohol 0.006 ± 0.000 >0.1% 
Oleic acid 0.024 ± 0.001 0.047 ± 0.001 
l-Menthol  0.047 ± 0.003 0.304 ± 0.048 
Tween 20 0.048 ± 0.001 0.189 ± 0.019 
Sefsol 218 0.061 ± 0.000 0.236 ± 0.010 
1,8-Cineol  0.179 ± 0.027 >1% 
Tween 80 0.507 ± 0.087 0.066 ± 0.004 
Tween 85 0.599 ± 0.018 0.065 ± 0.002 
Pluronic F-127 1.040 ± 0.019 1.331 ± 0.027 
Span 20 1.304 ± 0.451 0.081 ± 0.005 
Brij 58 1.352 ± 0.032 0.166 ± 0.012 
Tween 40 2.127 ± 0.052 0.096 ± 0.004 
Tween 60 2.372 ± 0.214 0.083 ± 0.004 
Pluronic P-84 2.415 ± 0.069  2.372 ±0.172 
Benzyl alcohol 2.650 ± 0.026 7.310 ± 0.012 
Sodium decanoate 3.190 ± 0.117  2.950 ± 0.046 
Sodium dodecyl sulfate 4.259 ± 0.037 0.283 ± 0.014 
Span 40 4.266 ± 0.197 0.324 ± 0.048 
Span 60 4.718 ± 0.065 0.274 ± 0.042 
Ethanol  8.011 ± 0.075 67.160 ± 2.318 
Urea 8.990 ± 0.039 >50% 
n-Propanol 10.001 ± 0.038 44.533 ± 1.023 
Transcutol  12.021 ± 1.056 >75% 
Dimethyl sulfoxide 14.189 ± 0.183 >75% 
Propylene glycol 14.725 ± 0.211 >75% 
1-Methyl-2-pyrrolidone 16.130 ± 0.396 >20% 
PEG 400 32.548 ± 0.297 >75% 
Span 80 > 5% 0.048 ± 0.004 
Ethyl oleate > 0.1% 0.051 ± 0.002 
Cetylpyridinium chloride > 5% > 5% 
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1.3.10. HTS of various types and concentrations of CPEs on SCLL fluidity 
The relationship between fluidity of SCLLs and different concentrations of CPEs is 
shown in Fig. 1-13a and b for lipophilic and amphiphilic CPEs, and hydrophilic CPEs, 
respectively. A concentration-dependent pattern similar to the FL leakage profile was observed, 
unless type II with an intercept could not be observed. Most CPEs promoted the fluidity of 
SCLLs similar to the type II profile. The EC10, fluidity of each CPE is shown in Table 1-4. 
However, several CPEs promoted relatively low SCLL fluidity (less than 10%) within the 
concentrations used in this study; e.g. cetylpyridinium chloride, propylene glycol, Transcutol, 
urea, dimethyl sulfoxide, PEG 400, lauryl alcohol and 1,8-cineol. Among the CPEs, lipophilic 
CPEs provided lower EC10, fluidity in comparison with hydrophilic CPEs. For amphiphilic CPEs, 
no clear relationship was found between the HLB and EC10, fluidity value (data not shown). 
 
1.3.11. The relationship between fluidity and FL leakage from SCLLs 
Figure 1-14a shows the relationships between fluidity and FL leakage from SCLLs for 
various types of CPEs. According to the similarity in the profile patterns, the tested CPEs were 
categorized into 5 groups (A-E) as shown in Fig. 1-14b. Category A contains CPEs that 
promoted similar degree of FL leakage and the fluidity of SCLLs. The profile of this category 
showed a linear correlation between FL leakage and fluidity of SCLLs. Category B includes 
CPEs that promoted high fluidity but low FL leakage, the plots parallel to the Y-axis was 
observed. Similarly, CPEs in category C promoted high fluidity of SCLLs, however, at higher 
concentrations, higher FL leakage was then observed. The plots of this category were first 
parallel to the Y-axis, after a marked increase in fluidity, the curve bended toward the X-axis. 
Therefore, two slopes could be found in this category’s profile. Category D includes CPEs that 
promoted high FL leakage but low fluidity. The plot in this category CPEs was almost parallel 
to X-axis. Finally, category E contains CPEs that could not be classified into any of the 
previously defined categories, then the CPEs that exhibited scattering profile were classified in 
this category. 
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Fig. 1-13. Relationship between fluidity of SCLLs and CPE concentration; (a) lipophilic and 
amphiphilic CPEs, (b) hydrophilic CPEs. Each value represents the mean ± S.E. (n = 3). 
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Fig. 1-14. Relationship between SCLL fluidity and FL leakage by addition of various types of 
CPEs and their categorization, (a) observed data, (b) categorization. 
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1.4. Discussion 
 
Use of CPEs represents an easy and well-established approach to enhance the skin 
penetration of drugs. One of the mechanisms for the effects of CPEs can be explained by the 
lipid-protein-partitioning (LPP) theory35), in which CPEs act by disrupting the highly ordered 
lamellar structure of SC lipids, interacting with intracellular proteins to promote drug 
permeation through the corneocyte layer, and increasing the partitioning of drugs into the SC. 
SCLLs exhibit similar characteristics to the SC intercellular lipids without the proteins 
associated with the SC. Thus, SCLLs were utilized in the present study as a model membrane 
to assess the interaction of various CPEs specifically on the SC lipid region. 
In the present study, the SCLLs which comprised similar lipid composition to the 
intercellular lipids were prepared. This SCLL vesicle was obtained as unilamellar by an 
extrusion method. This SCLL morphology can be more quantitatively characterized with 
regards to lipid concentration, surface area and volume as well as a higher stability than 
multilamellar vesicles which present similar multilamellar structure to the SC lipids. Borate 
buffer pH 9.0 was used to prepare SCLLs as well as to dissolve CPEs, regardless of the skin 
pH of 4-7, to maintain the stability of SCLL vesicle derived from ionized moieties of 
cholesterol sulfate and free fatty acids in this pH30).  
A fluorescent hydrophilic marker, FL, was entrapped in SCLLs in order to monitor the 
degree of its membrane rupture by CPEs. Furthermore, fluidity of the SCLL membrane was 
also measured using various lipophilicities of probes in an HTS manner. These experiments 
were compared with conventional methods for determination of skin penetration-enhancing 
effect of chemicals: in vitro permeation and impedance studies using hairless rat skin. A well-
known CPE contained in many topical and transdermal formulations, ethanol, was used in the 
first step to test for the suitability of this HTS approach. 
The present skin permeation experiments of caffeine were conducted in asymmetric 
conditions in order to determine the penetration-enhancing effect of ethanol. The increase in 
ER by ethanol was found to be concentration dependent. A similar ethanol concentration-
dependent effect was observed when using indomethacin in a previous study36). The highest 
permeation of caffeine was not observed at the highest ethanol concentration, because highly 
concentrated ethanol dehydrates the skin membrane and reduces the skin permeation of 
drugs37). Previous study also found that the skin permeability of hydrophilic drugs was 
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increased but inversely decreased by low and high concentration of ethanol, respectively38). In 
addition, X-ray diffraction data confirmed that low concentrations of ethanol disturbed the 
short lamellar structure of SC lipids, but the high concentration caused an aligned structure39). 
Skin impedance has been reported to well correlate with drug permeability through 
skin8,38). Then, back skin impedance was determined to increase the sensitivity of ethanol effect 
on the skin impedance. Ethanol could reduce the skin impedance and clearly alter the flux of 
low molecular weight ions through the skin38). Nevertheless, the obtained results in this study 
did not show linearity between the reduction in skin impedance and the increase in ER. This is 
because low concentrations of ethanol could greatly reduce the skin impedance but higher 
concentrations remained stable. Therefore, the reduction in skin impedance by ethanol might 
not be a quantitative indicator for the skin penetration-enhancing effect in this case.  
FL leakage was observed from SCLL at low (≥5%) to high (~100%) concentrations of 
ethanol and the degree was ethanol-concentration dependent, suggesting that the disruption 
effect on the SCLL membrane was closely related to ethanol concentration. Ethanol has been 
reported as a markedly effective skin penetration enhancer by various mechanisms; increase in 
drug solubility, improvement in drug partitioning into the SC, modification of thermodynamic 
activity of drugs, solvent (ethanol) drag effect across the skin, fluidization and extraction of SC 
lipids, and the structure modification of SC keratin37,40). SCLLs used in the present experiment 
are model SC lipids with a lack of cellular proteins such as keratin10). Therefore, the present 
SCLL leakage results might not be totally predictive for all mechanisms associated with the 
skin penetration-enhancing effects of ethanol. 
SCLLs mimic intercellular lipids in SC where CPEs act. Then, three different 
fluorescent probes; DPH, TMA-DPH and ANS, were used to determine the SCLL membrane 
fluidity in order to better understand the effect of ethanol on the lipid packing. High fluidity in 
the SCLL membrane represents a high degree of lipid molecule disorganization, which 
provides high permeability of drugs through the bilayer41). The effect of ethanol on the fluidity 
of SCLL was determined, especially in the region where each fluorescent probe was contained, 
as depicted in Fig. 1-15. DPH and TMA-DPH serve as markers for determination of molecular 
movement in the hydrophobic core and superficial surface of SCLLs31), respectively. The effect 
of ethanol on the SCLL fluidity using DPH and TMA-DPH showed similar patterns. In the 
present study, lower ethanol concentrations could not promote SCLL fluidity and the effect 
was clearly found with more than 50% ethanol. On the other hand, ANS, a marker of molecular 
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movement on the exterior membrane surface31), changed the membrane fluidity even at low 
ethanol concentrations, and good linearity was observed between SCLL fluidity and ethanol 
concentration. These results using three fluorescent probes provided a possible effect of ethanol 
on the SCLL membranes. Thus, ethanol mainly disrupted the polar head region at the outside 
of liposome membrane similar in a previous report42). Good correlations were obtained 
especially in the FL leakage and SCLL fluidity detected using the ANS probe, indicating that 
SCLLs could be an optional model to investigate the skin penetration-enhancing effects of 
CPEs as well as their mode of actions. 
 
Fig. 1-15. Location of three different fluorescent probes in SCLLs. 
 
Furthermore, the effect of various types and concentrations of CPEs on the FL leakage 
and SCLL membrane fluidity measured using a DPH probe, which serves as a marker for 
molecular movement in the hydrophobic region of SCLL43), was systematically evaluated. 
Lower EC10, leakage and EC10, fluidity were observed from lipophilic CPEs than hydrophilic CPEs. 
It has been discussed previously that more lipophilic compounds penetrate more easily into the 
SCLL membrane and more effectively reduce the barrier function of the membrane22). 
However, several CPEs slightly promoted leakage and fluidity, thus calculation of the exact 
EC10 value was difficult. 
From the relationship between SCLL fluidity and FL leakage, 5 categories of CPEs 
could be observed. Category A contained several non-ionic surfactants; e.g. Tween 20 and 80, 
Pluronic F-127 and P-84, fatty acids and its derivatives such as oleic acid, sodium decanoate, 
Sefsol 218 as well as l-menthol. Fatty acids such as oleic acid was reported to disturb the 
packing of lipids and thereby increase the fluidity of lipids as well as form a permeable defect 
within the SC lipids44,45). 
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Category B contained Span 40, 60 and 80, and sodium dodecyl sulfate. This group 
comprised mainly hydrophobic non-ionic surfactants (HLB 4-7) and anionic surfactants (HLB 
40). These CPEs may insert into the hydrophobic region of SCLLs to promote higher 
membrane fluidity but not strong enough to promote the leakage from the SCLLs. 
Most non-ionic surfactants such as Tween 40, 60, 85, Span 20 and Brij 58 were 
classified into category C. These CPEs showed a similar action to the CPEs in category B, by 
fluidization of SCLL. In addition, high leakage was also observed at a higher concentration. 
This phenomenon might be due to the insertion of these non-ionic surfactant molecules in the 
hydrophobic area of SCLL. At a higher concentration, the degree of fluidization is strong 
enough to disturb the SCLLs structure consequently allowing FL to leak outside. 
Non-ionic surfactants could be categorized into either category A, B or C. These 
findings are in good agreement with the skin penetration-enhancing mechanisms reported that 
surfactants may intercalate into lipid bilayers of SC, resulting to increase fluidity of 
intercellular SC lipids which finally solubilize and extract the lipid components46). The effect 
of surfactants on the SCLLs could vary from mild to strong as could be observed from each 
category. However, the surfactant effects on the keratin filament could not be observed using 
this model membrane. 
The following CPEs; n-propanol, propylene glycol, Transcutol, PEG 400, ethanol, 
lauryl alcohol, benzyl alcohol, dimethyl sulfoxide and 1,8-cineol were classified in category 
D. Alcohols and glycols as classified under this category were reported to interact the aqueous 
domain of the lipid bilayers which increase the drug solubility in the skin47). In addition, ethanol 
has been reported to extract and fluidize SC lipids48-50).  Dimethyl sulfoxide has been shown to 
change keratin conformation and interact with SC lipids51,52). However, the interactions of these 
CPEs with SC lipids were mainly on the polar head region39,51,53). Therefore, low fluidity in the 
hydrophobic chain of SCLL lipids was observed in the present study.  
1-Methyl-2-pyrrolidone, ethyl oleate, urea and cetylpyridinium chloride were classified 
in category E, in which the profile could not be categorized in any previous categories. The 
skin penetration-enhancing effect of urea and its derivatives are from keratolytic and 
moisturizing effects; cationic surfactants act on the skin proteins; whereas pyrrolidone 
derivatives act on the drug partitioning into SC to alter the solvent nature of SC54,55). In addition, 
ethyl oleate is highly lipophilic (log Ko/w 6.89). Its low solubility in SCLL dispersion medium 
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might be a reason for low disruption effect on the SCLLs since ethyl oleate could not be 
exposed and penetrated into the SCLLs membrane. Thus, these reasons might support category 
E of exhibiting no trend in the SCLL fluidity and FL leakage plot. 
The modes of action for each category of CPEs could be proposed as follows: CPEs in 
the categories A, B and C might mainly act by fluidization of SC lipids, although the degree of 
fluidization is different among categories. The degree of fluidization of CPEs in category A is 
strong, so that they could disrupt the SC lipids and promote the diffusion of drugs through the 
SC lipids, which is evident from high FL leakage profile. Category B provides mild degree of 
fluidization, therefore they could not promote the diffusion of drugs through SC lipids. 
Category C is similar to category B, but the degree of fluidization is strong enough to disrupt 
the SC structure at their higher concentrations. On the other hand, category D might act at the 
lipid polar head group or at the aqueous region between the lipid head groups. Finally, category 
E did not manifest any trend, thus its mechanism of action cannot be identified using the present 
method on the SCLL model.  
 
1.5. Chapter conclusion 
 
The present HTS approach using SCLLs could be a promising model to determine the 
effect of various kinds of CPEs on the skin permeability of drugs, because a good correlation 
was obtained from SCLL-based experiments and skin permeation study using ethanol as a 
model CPE. The ease of handling of the various fluorescent probes could also identify the 
possible mechanisms of action of CPEs for enhancing the skin permeation of drugs. The present 
HTS approach provided benefits over other conventional skin penetration and skin impedance 
studies, i.e., small quantity of sample is required, and rapid, simultaneous and simple 
determination can be performed using a fluorescent microplate reader and can avoid the use of 
animals which impractical in ethical issues. The presently evaluated approach exhibited good 
feasibility to test new CPE candidates in the skin formulation development.  
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Chapter 2  
 
Development of penetration enhancing vesicular carriers based on the skin penetration- 
enhancing properties of materials 
 
2.1.  Introduction 
 
Vesicular carriers including liposomes and niosomes have been received high attention 
in the field of skin drug delivery during this few decades due to their ability to entrap and act 
as chemical carriers to enhance the skin penetration of both hydrophilic and lipophilic 
molecules56-58). The main compositions of liposome and niosome formulations are 
phospholipids and non-ionic surfactants, respectively, which can spontaneously form the 
structure of closed bilayers vesicles as they confront with water7). The mechanisms to enhance 
the skin penetration of drugs using vesicular carriers have been proposed as 1) free drug 
operation, 2) intact vesicular penetration, 3) vesicle adsorption to and/or fusion with the SC 
and 4) penetration enhancing effect59,60). However, conflicting results on these mechanisms 
have been found in spite of much efforts made by many researchers. 
One of the well-accepted mechanisms for the skin penetration-enhancement effect of 
vesicles is the penetration of the amphiphilic components (phospholipids and non-ionic 
surfactants) from the vesicles to skin and perturbation of the packing of SC lipids59-62). From 
this reason, the amphiphilic composition of vesicles is an important optimization factor that 
should be considered to enhance the skin penetration of drugs. Several studies have focused on 
the vesicular characteristics, for examples, morphology, vesicular size, surface charge, 
entrapment efficiency, transition temperature, or elasticity as factors to optimize and enhance 
the skin penetration of drugs63-65).  Other studies have developed novel classes of vesicular 
carriers to obtain high penetration enhancing effect, by addition of edge activators or CPEs into 
the classical liposomes and niosomes63,66-68). However, very limited studies have considered 
the effect of the amphiphilic compositions as an optimization factor to enhance the skin 
permeation of drugs.  Understanding the effect of vesicle compositions on their penetration-
enhancing ability could enable researchers to develop vesicles that intended to improve the 
skin penetration of drugs. 
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This study was aimed to develop a novel approach to formulate penetration-
enhancement vesicles. This approach was based on the selection of the vesicular carrier’s 
composition by in vitro skin permeation screening to assess the suitable compositions with high 
skin penetration-enhancing effect for a hydrophilic model drug; caffeine.  Liposomes and 
niosomes were prepared from their main compositions; phospholipids and non-ionic 
surfactants, respectively.  The skin penetration-enhancing property of these vesicles was then 
evaluated and compared to their composition dispersions. In addition, two kinds of experiments 
were done to clarify the possible mechanism of liposomes as follows: the excised skin was 
pretreated for 1 h with caffeine-free phospholipid dispersions and liposomes, and caffeine 
solution was added to determine its skin permeation. Separately, caffeine permeation 
experiments were done using physical mixture of blank liposomes and caffeine solution 
(caffeine-spiked liposomes) and caffeine-entrapped liposomes (caffeine was entrapped only in 
liposomes). 
 
2.2.  Materials and methods 
 
2.2.1. Materials 
  Phospholipids including 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC), 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dimyristoyl-sn-glycero-3-phospho-
glycerol, sodium salt (DMPG), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-
dipalmitoyl-sn-glycero-3-phosphoglycerol, sodium salt (DPPG), 1,2-distearoyl-sn-glycero-3-
phosphocholine (DSPC), 1,2-distearoyl-sn-glycero-3-phosphoglycerol, sodium salt (DSPG), 
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dioleoyl-sn-glycero-3-phospho 
glycerol, sodium salt (DOPG) were purchased from NOF Corporation (Tokyo, Japan). 1,2-
Dilauroyl-sn-glycero-3-phosphoglycerol, sodium salt (DLPG) was obtained from Olbracht 
Serdary Research Laboratories (Toronto, ON, Canada). Tween 20, 40, 60, 80, 85 and Span 20, 
40, 60, 80 were obtained from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). Brij 35 was 
obtained from MP Biomedical, LLC (Illkirch, France). Cholesterol was purchased from Sigma-
Aldrich (St. Louis, MO, USA). Caffeine, chloroform, methanol and ethanol were purchased 
from Wako Pure Chemicals Industries, Ltd. (Osaka, Japan). Propylene glycol was purchased 
from Kanto Chemical Co., Inc., (Tokyo, Japan). These reagents were used without further 
purification. 
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2.2.2. Determination of skin penetration-enhancing effect of phospholipid and non-ionic 
surfactant dispersions 
The skin penetration-enhancing effect of different types of phospholipid and non-ionic 
surfactant dispersions were determined using a diffusion cell array system (Ikeda Scientific 
Co., Ltd., Tokyo, Japan). This system is comprised of 12 wells wherein the donor compartment 
is above the receiver chamber with the excised skin sandwiched between them. Effective 
permeation area and receiver volume for each well are 0.785 cm2 and 1.36 mL, respectively. 
The study was performed using excised abdominal skin from hairless rat after removing 
subcutaneous fat as described in sections 1.2.2. and 1.2.3.  The skin was excised and cut into 
two pieces of 3 x 4 cm size from the middle line of rat abdomen and set on the diffusion cell 
array system as shown in Fig. 2-1. At first, 1.0 and 1.36 mL PBS were added in the donor and 
receiver chamber, respectively, for 1 h for skin hydration. After that, PBS was removed from 
donor compartment and replaced with 200 µL of 3% w/v phospholipids/non-ionic surfactants 
dispersions containing caffeine in PBS at a concentration of 100 mM. The skin permeation 
experiment was performed at 32°C using a thermo-shaker at the rotation speed of 200 rpm and 
the receiver solution was stirred using a stir ball for 12 h. At the end of the permeation 
experiment, the receiver solution was collected to determine the amount of caffeine that 
permeated per unit of skin area (Q) by an HPLC. Caffeine solution (100 mM) in PBS was used 
as a control and calculated for skin penetration-enhancement ratio (ER) of each sample by the 
following equation;  
 
ER = (
𝑄𝑠𝑎𝑚𝑝𝑙𝑒 
𝑄𝑐𝑜𝑛𝑡𝑟𝑜𝑙
)     (6) 
where Qsample and Qcontrol are the cumulative amount of caffeine permeated per unit area of skin 
over 12 h from different phospholipids/non-ionic surfactants and control solution, respectively. 
Fig. 2-1. Diffusion cell array system for in vitro skin permeation experiment.  
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2.2.3. Preparation of liposomes and niosomes 
Liposomes/niosomes were prepared using phospholipids/non-ionic surfactants and 
cholesterol in the ratio of 4:1 w/w.  The compositions were dissolved in chloroform: methanol 
(2:1 v/v) in a round-bottomed flask. The solvent was evaporated to form the thin film using a 
rotary evaporator under reduced pressure. The obtained film was purged with N2 gas and kept 
overnight to remove the trace organic solvent. After that, the flask was immersed in a water 
bath at 90°C for annealing the thin film for 30 min, and then 100 mM caffeine in PBS solution 
was added to adjust phospholipids/non-ionic surfactants concentration to 3% (w/v). The thin 
film was hydrated for 30 min. The resulting liposomes/niosomes containing caffeine were then 
sonicated using a probe sonicator (VCX-750, Sonics & Materials Inc., Newtown, CT, USA) 
for 30 s. Next, 4 cycles of freeze-thaw process were performed by immersing the flask in liquid 
N2 and in 90°C-water bath for 3 min each. The obtained liposomes were further extruded using 
a mini-extruder (Avanti Polar Lipids, Inc., Alabaster, AL, USA) assembled with a membrane 
filter (with pore sizes of 400, 200 and 100 nm, Whatman® track-etched membranes, GE 
Healthcare Japan, Tokyo, Japan). All final liposomes/niosomes containing caffeine were kept 
at room temperature and freshly used for the skin permeation experiment within the next day 
after preparation. In the final formulation, caffeine was contained both in the inside and outside 
of vesicles. These vesicle formulations were used to evaluate the caffeine permeation through 
skin. 
Caffeine-free liposomes (blank liposomes) were also prepared with the same 
procedure without addition of caffeine.  
 
2.2.4. Characterizations of liposomes and niosomes 
Particle size and zeta potential  
The particle size and zeta potential of liposomes and niosomes were measured after 
100-fold dilution with PBS using a Zetasizer Nano ZS (Malvern Instruments Ltd., Malvern, 
UK). The size measurements were performed at 25°C and a scattering angle of 90°. Each 
individual zeta potential measurement was repeated for at least 10 readings from each sample.  
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Entrapment efficiency 
The entrapment efficiency (EE) of caffeine in each vesicle formulation was determined 
by ultracentrifuge technique to evaluate the caffeine distribution in either inside and outside of 
vesicle formulations. Final vesicles suspension (400 µL) was put in a centrifuge tube and 
centrifuged using a micro-ultracentrifuge (Himac CS120GXII, Hitachi Koki Co., Ltd., Tokyo, 
Japan) to separate the vesicles pellet (entrapped drug, Edrug) from the supernatant (unentrapped 
drug, Udrug). The supernatant was collected and the unentrapped (free) caffeine content was 
determined after 10-fold dilution with ethanol followed by 10-fold with PBS. In addition, the 
entrapped drug content in vesicles was determined by dispersing the packed vesicle pellet with 
400 µL PBS and further disrupting with 10-fold ethanol followed by dilution with 10-fold PBS. 
Caffeine contents were analyzed by an HPLC and the % EE was calculated according to the 
following equation. 
 
% Entrapment efficiency (EE)  = (
𝐸𝑑𝑟𝑢𝑔 
𝐸𝑑𝑟𝑢𝑔+ 𝑈𝑑𝑟𝑢𝑔
) 𝑥 100  (7) 
 
For niosomes, the EE was determined from the caffeine content in supernatant as shown in the 
following equation; where total drug (Tdrug) was obtained from vesicles suspension disrupted 
with ethanol and PBS as in above mentioned procedure. 
 
% Entrapment efficiency (EE)  = (
𝑇𝑑𝑟𝑢𝑔−𝑈𝑑𝑟𝑢𝑔
𝑇𝑑𝑟𝑢𝑔
) 𝑥 100  (8) 
 
Differential Scanning Calorimetry 
The phase transition temperature (Tm) was determined for liposomes and niosomes 
membrane by a DSC Thermo plus EVO/ DSC8230, Rigaku Corporation, Japan). About 5 mg 
of liposome pellets obtained from the ultracentrifugation process previously described or 
niosomes suspension were placed in an aluminum pan. An empty pan was used as a reference. 
The DSC heating scan was performed at a heating rate of 5.0°C/min in a 15–80°C range. 
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2.2.5. In vitro skin permeation experiments of caffeine from liposomes and niosomes 
Excised abdominal skin from hairless rat was mounted in a vertical-type Franz diffusion 
cell (effective permeation area of 1.77 cm2 and receiver cell volume of 6.0 mL) with the SC 
side facing the donor cell and the dermal side facing the receiver cell. The receiver cell was 
filled with 6.0 mL PBS. 1.0 mL PBS was added to the donor cells for 1 h for skin hydration. 
Then, 400 µL of liposomes/niosomes containing caffeine at a concentration of 100 mM were 
replaced in the donor compartment to determine its skin permeation at 32°C over 8 h, while 
the receiver solution was agitated at 500 rpm using a magnetic stirrer. At predetermined times, 
0.5 mL aliquots were collected and the same volume of PBS was added to keep the volume 
constant. The amount of caffeine permeated through skin was determined by HPLC. 
 
2.2.6. Determination of the effect of pretreatment of caffeine-free phospholipid dispersions 
and liposomes on the caffeine permeation through skin 
 Selected caffeine-free liposomes (400 µL) prepared using phospholipids (DPPG, DLPC 
or DSPG) were applied onto the SC surface of skin for 1 h after the hydration period with PBS. 
Phospholipid dispersions (3% DPPG, DLPC or DSPG) without caffeine were also applied on 
skin for comparison. Then, the liposomes or phospholipid dispersion without caffeine were 
removed from the skin surface by washing with 1.0 mL fresh PBS for 10 times. Caffeine 
solution (100 mM, 400 µL) was then applied on the skin. The skin permeation experiment was 
conducted using vertical-type Franz diffusion cell for 8 h as previously described in the section 
2.2.5.  
 
2.2.7. Determination of the skin permeation of caffeine from the physical mixture of blank 
liposomes and caffeine solution (caffeine-spiked liposomes) 
The caffeine-spiked liposomes containing 3% phospholipid and 100 mM caffeine was 
prepared by mixing the same volume of the double-concentrated liposomes (preparation 
method was similar to the final liposomes as above) and 200 mM caffeine. The resultant 
caffeine-spiked liposomes (400 µL) were used for the skin permeation experiment of caffeine 
using vertical-type Franz diffusion cell for 8 h as previously described in the section 2.2.5.  
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2.2.8. Determination of the skin permeation of caffeine from caffeine-entrapped liposomes  
Caffeine-entrapped DPPG, DLPC and DSPG liposomes were obtained by 
ultracentrifugation separation as described previously. In the preparation process, free caffeine 
was totally removed and the remained caffeine-entrapped liposomes pellet was dispersed with 
PBS (400 µL). The skin permeation experiment using this caffeine-entrapped liposome 
formulation was performed and compared with the same concentration of free caffeine solution. 
 
2.2.9. Determination of caffeine content 
The concentration of caffeine was determined as described in the section 1.2.5. 
 
2.2.10. Statistical analysis 
Data were expressed as the mean ± standard error (S.E.) or standard deviation (S.D.). 
The differences among the obtained data were analyzed using unpaired t-test. The differences 
were considered to be significant when p < 0.05. 
 
2.3.  Results 
 
2.3.1. Skin penetration-enhancing effect of phospholipid and non-ionic surfactant dispersions 
The ER of caffeine permeation in the presence of 3% phospholipid/non-ionic surfactant 
dispersion in PBS against that of free caffeine solution in PBS is shown in Fig. 2-2. DSPC and 
DPPG dispersions significantly enhanced the skin permeation of caffeine (ER 1.93 and 1.57, 
respectively), whereas DOPG dispersion provided the lowest skin permeation of caffeine (ER 
= 0.38). While the other phospholipid dispersions had no or little skin penetration-enhancing 
effect against the control group. Non-ionic surfactants including Brij 30 and Span 20 
dispersions showed significantly higher ER (7.72 and 3.53, respectively) as compared to the 
ER obtained from phospholipids dispersion. In addition, other non-ionic surfactants resulted in 
about 1.3-2.0 times ER, wherein Tween 20, 40 and 60 showed significant difference in the 
caffeine permeation compared to the control solution as shown in Fig. 2-3. 
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Fig. 2-2. ER of caffeine permeation through skin from different phospholipid dispersions. Each 
value represents the mean ± S.E. (n = 3–4). *: p < 0.05 significantly different from control. 
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Fig. 2-3. ER of caffeine permeation through skin from different non-ionic surfactants 
dispersion. Each value represents the mean ± S.E. (n = 3–4). *: p < 0.05 significantly different 
from control.  
 
2.3.2. Characteristics of liposomes and niosomes 
Table 2-1 shows the characteristics of various types of liposomes and niosomes 
prepared in this study. All liposome formulations had a small diameter in a range of 110-185 
nm. Phosphatidylcholine (DLPC, DMPC, DPPC, DSPC, DOPC) liposomes showed larger 
particle size than phosphatidylglycerol (DLPG, DMPG, DPPG, DSPG and DOPG) liposomes. 
The zeta potential of these phosphatidylcholine liposomes had quite neutral charge, whereas 
phosphatidylglycerol liposomes had negatively surface charge less than -40 mV. The EE was 
less than 50% and Tm was within a range of 41-66°C for all liposomes. 
For niosomes, Span niosomes showed bigger particle size than Tween and Brij 
niosomes. This may be due to different hydrophilicity/hydrophobicity of the non-ionic 
surfactants. The zeta potential of niosomes was different depending on the type of non-ionic 
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surfactants used. The EE in all niosomes was low. Only Tween 60 niosomes could reach 33.9%. 
Tm of all niosomes was within a range of 11-28°C. Brij 30 dispersion could provide high ER, 
although niosomes were not formed (the oil droplet segregation was observed).  
 
Table 2-1. Characteristics of liposomes and niosomes  
Main component Tm 
 (°C) 
EE 
(%) 
Particle 
diameter  
(nm) 
Polydispersity 
Index 
Zeta 
potential 
(mV) 
DLPC (12:0) 49.8 15.44 ± 0.74 161.2 ± 0.3 0.211 ± 0.023 0.2 ± 0.5 
DLPG (12:0) -  23.98 ± 0.42 109.3 ± 0.3 0.088 ± 0.016 -41.2 ± 3.0 
DMPC (14:0) 49.0 18.68 ± 0.54 165.3 ± 2.0 0.111 ± 0.079 -1.3 ± 1.6 
DMPG (14:0) 65.3 27.95 ± 1.10 130.2 ± 0.8 0.059 ± 0.011 -40.3 ± 3.5 
DPPC (16:0) 47.6 17.46 ± 0.63 169.9 ± 2.4 0.250 ± 0.011 -1.3 ± 0.7 
DPPG (16:0) 41.5 13.35 ± 0.03 152.1 ± 0.9 0.164 ± 0.016 -44.3 ± 2.5 
DSPC (18:0) 51.7 12.93 ± 0.15 184.6 ± 3.4 0.214 ± 0.005 -0.5 ± 1.2 
DSPG (18:0) 62.8 21.14 ± 0.27 162.1 ± 0.9 0.096 ± 0.007 -45.1 ± 1.0 
DOPC (18:1) 65.8 49.08 ± 1.27  143.3 ± 1.0 0.070 ± 0.007 -6.6 ± 1.2 
DOPG (18:1) 54.5 45.38 ± 0.11  110.7 ± 0.5 0.116 ± 0.122 -41.6 ± 1.7 
Span 80  27.7 7.8  343.4 ± 31.7 0.313 ± 0.018 -22.3 ± 0.7 
Span 40  24.5 2.0  410.7 ± 15.2 0.239 ± 0.015 -20.2 ± 1.2 
Span 20  25.4 3.6  342.9 ± 18.9 0.236 ± 0.029 -12.6 ± 0.6 
Tween 85  11.5 8.0  77.2 ± 0.2 0.103 ± 0.006 -10.5 ± 0.1 
Tween 60  24.5 33.9  119.4 ± 1.3 0.125 ± 0.008 -3.8 ± 0.2 
Brij 35  40.6 4.1  122.7 ± 0.2 0.132 ± 0.011 -1.6 ± 0.4 
Each value represents the mean ± S.D. 
 
2.3.3. Skin permeation of caffeine from liposomes and niosomes 
Liposomes and niosomes prepared from different phospholipids/non-ionic surfactants 
were determined for their skin penetration-enhancing of caffeine. Time course of the 
cumulative amount of caffeine that permeated through skin from different kinds of liposomes 
and niosomes over 8 h are shown in Figs. 2-4 and 2-5. Typical lag time and following steady-
state permeation profiles were observed for all liposome preparations prepared in this 
experiment. Only DPPG, DLPC and DMPC liposomes significantly promoted the caffeine 
permeation compared to control (ER was 5.43, 3.17 and 2.17, respectively), whereas DPPC 
and DOPG liposomes decreased the caffeine permeation (ER was 0.21 and 0.27, respectively). 
No or little change in the skin permeation was found by the other phospholipid liposomes. For 
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niosomes, on the other hand, two types of niosomes including Span 20 and Tween 85 niosomes 
could significantly increase the skin permeation of caffeine as compared to control solution 
(ER 2.99 and 2.69, respectively). 
 
 
Fig. 2-4. Skin permeation profile of caffeine from different liposome formulations. Each value 
represents the mean ± S.E. (n = 3-5). *: p < 0.05 significantly different from control (free 
caffeine solution in PBS). 
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Fig. 2-5. Skin permeation profile of caffeine from different niosome formulations. Each value 
represents the mean ± S.E. (n = 3-5). *: p < 0.05 significantly different from control (free 
caffeine solution in PBS). 
 
Then, the skin penetration-enhancing effect by phospholipids/non-ionic surfactant 
dispersions and their liposomes/niosomes were compared as shown in Figs. 2-6 and 2-7. DLPC, 
DMPC and DPPG liposomes showed significant higher ER compared to their phospholipid 
dispersions, while DPPC and DSPC liposomes showed significant lower ER.  
Although DSPC phospholipid provided the highest ER in the form of dispersion, the 
skin permeation of caffeine from DSPC liposomes was substantially decreased. DPPG showed 
the enhancement effect both by phospholipid dispersion and liposome. However, its ER was 
highly increased by modification into the liposome formulation. In cases of other phospholipids 
such as DLPG, DMPG, DSPG, DOPC and DOPG, their liposomes showed no significant 
difference in the ER to those from their dispersions. 
The ER from all niosomes did not enhance compared to their dispersions. Especially 
Span 80 and Tween 60 niosomes provided significant lower ER than their dispersions. 
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Fig. 2-6. Comparison of ER of caffeine permeation obtained from phospholipid dispersions 
and liposomes. Each value represents the mean ± S.E. (n = 3–5). *: p < 0.05 significantly 
different from its phospholipid dispersion.  
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Fig. 2-7. Comparison of ER of caffeine permeation obtained from non-ionic surfactants 
dispersions and niosomes. Each value represents the mean ± S.E. (n = 3–5). *: p < 0.05 
significantly different from its non-ionic surfactant dispersion. 
 
2.3.4. Effect of pretreatment with caffeine-free phospholipid dispersions and liposomes on the 
skin permeation of caffeine  
DPPG and DLPC liposomes exhibited the highest skin penetration-enhancing effects 
among all liposomes, but DSPG liposomes exhibited low skin permeation of caffeine.  Then 
these three phospholipids were selected and 1 h-pretreatment experiment was done before skin 
permeation experiment from caffeine solution to clarify the possible effect of liposomes on the 
skin permeation of caffeine. As results, the pretreatment with phospholipid dispersions 
enhanced caffeine permeation for DLPC (ER = 1.35) and DPPG (ER = 2.47), but decreased for 
DSPG (ER=0.48) as shown in Fig. 2-8. 
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The pretreatment experiment was also performed using caffeine-free liposomes. 
Interestingly, the 1 h-pretreatment with caffeine-free liposomes showed different results: the 
lower ER was observed compared to the effect of pretreatment with phospholipids dispersions. 
The ER for caffeine-free DLPC, DPPG and DSPG liposomes were 0.87, 1.50 and 0.46, 
respectively, as shown in Fig. 2-8. 
 
Fig. 2-8. Effect of 1 h-pretreatment with caffeine-free phospholipid dispersions and liposomes 
on the ER of skin permeation of caffeine. Each value represents the mean ± S.E. (n = 3–5).  
*: p < 0.05 significantly different from control (no pretreatment; free caffeine solution in PBS). 
 
2.3.5. Effect of physical mixture of blank liposomes and caffeine solution (caffeine-spiked 
liposomes) on the skin permeation of caffeine 
In order to evaluate the contribution of caffeine contents in the inside and outside of 
liposomes on its skin permeation, physical mixture of blank liposomes and caffeine was applied 
on the excised skin to measure the skin permeation of caffeine. The results are shown in Fig. 
2-9. Caffeine-spiked DLPC or DSPG liposomes exhibited lower skin permeation of caffeine 
(ER was 0.58 and 0.44, respectively). On the other hand, only caffeine-spiked DPPG liposomes 
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significantly enhanced the skin permeation of caffeine (ER = 2.65) compared to control 
caffeine solution. 
 
Fig. 2-9. Time course of the cumulative amount of caffeine that permeated through skin from 
physical mixture of blank liposomes and caffeine solution (caffeine-spiked DPPG, DLPC and 
DSPG liposomes). Each value represents the mean ± S.E. (n = 3–5). *: p < 0.05 significantly 
different from control (free caffeine solution in PBS). 
 
2.3.6. Effect of caffeine-entrapped liposomes on the skin permeation of caffeine  
Next, caffeine-entrapped liposomes were evaluated and the skin permeation data for 
caffeine was shown in Fig. 2-10. Caffeine-entrapped DPPG liposomes showed the highest 
caffeine permeation (ER = 4.39), whereas caffeine-entrapped DLPC liposomes enhanced about 
1.65-fold compared to caffeine solution which contained the same concentration as in liposome 
formulations. No penetration enhancing effect was observed for the caffeine-entrapped DSPG 
liposomes. 
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Fig. 2-10. Time course of the normalized cumulative amount of caffeine that permeated 
through skin from caffeine-entrapped DPPG, DLPC and DSPG liposomes. Each value 
represents the mean ± S.E. (n = 3–5). *: p < 0.05 significantly different from control (free 
caffeine solution in PBS). Y-axis was calculated with dividing the cumulative amount of 
caffeine that permeated through skin by the total amount of applied drug. 
 
2.4.  Discussion  
 
Although several studies have reported on the potential of vesicular carriers including 
liposomes and niosomes as a topical/transdermal drug delivery system compared to 
conventional formulations56,69,70), there seems to be a general lack of understanding among 
researchers regarding on the formulation factors of liposomes and niosomes to provide high 
skin penetration-enhancing effect. Therefore, the present study was mainly focused on the 
designing strategies of liposome and niosome formulations by investigating the effect of their 
compositions on the enhanced skin permeation of drugs.  
In the present study, skin penetration-enhancing effect of different phospholipids and 
non-ionic surfactants was evaluated using caffeine as a model penetrant, since the selection of 
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phospholipids and non-ionic surfactants must be very important to design suitable vesicle 
formulations. The skin permeation of caffeine was significantly improved by DPPG and DSPC 
dispersions, whereas DOPG dispersion markedly decreased the skin permeation. In addition, 
the other phospholipids had no or little skin penetration-enhancing effects against the control 
group (Fig. 2-2). On the other hand, significant improvement in skin permeation of caffeine 
was observed with Span 20, Brij 30, Tween 20, 40 and 60 compared to other non-ionic 
surfactants. These results strongly supported the concept of the present study, Thus, the vesicle 
compositions in the liposome or niosome formulations must be considered in the development 
of such formulations (Fig. 2-3).  
In addition, the prepared liposomes and niosomes had a small size (80-410 nm). Tm, EE 
and zeta potential were dramatically affected by changes of phospholipid/ non-ionic surfactant 
compositions (Table 2-1). However, the reason for the differences in the skin penetration-
enhancing effects depending on the compositions is still unknown.  
Next, the skin penetration-enhancement effect of liposome and niosome formulations 
was evaluated (Fig. 2-4). The reason why only three liposome formulations made of DPPG, 
DLPC and DMPC showed higher skin permeation than other liposome formulations and 
control solution can be explained as follow, 1) Some liposomes might have a rigid structure 
that could form an extra lipid barrier onto the skin surface which retards the skin permeation 
of caffeine, and this extent must be different depending on the phospholipids, or 2) some 
liposomes might release caffeine in a slower rate than other phospholipid-based liposomes 
probably due to  the interaction between the drug and phospholipids71).  
On the other hand, the same kind of findings were observed in the case of niosome 
formulations (Fig. 2-5). Only Span 20 and Tween 85 niosomes showed significant skin 
penetration-enhancing effect for caffeine, indicating that the selected type of non-ionic 
surfactants in niosome formulations could influence the skin permeation of drugs. 
As a comparison, the skin penetration-enhancement ratios (ER) that obtained from the 
phospholipid dispersions were different from their liposome formulations (Fig. 2-6), 
suggesting that liposome vesicles containing caffeine have different mechanisms to increase 
the skin permeation than the phospholipid dispersions. Interestingly, DPPG dispersion as well 
as its liposome formulation resulted in high ER of caffeine, indicating that the DPPG is a 
promising phospholipid to fabricate liposomes. The same phenomenon was observed in the 
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case of niosome formulations. The performance of these formulations was affected by their 
compositions (Fig. 2-7). The non-ionic surfactant dispersions of Span 20 and Tween 85 as well 
as their niosomes showed high ER of caffeine, indicating that these non-ionic surfactants are 
very promising ones to develop niosomes. Further studies are necessary to fully understand the 
reason for the differences in the skin penetration-enhancement effects beween 
phospholipid/non-ionic surfactants and their liposomes/niosomes as well as among different 
compositions. 
To further understand the possible mechanism of action of each phospholipid, the skin 
pretreatment approach and following skin permeation experiment of caffeine were carried out 
using caffeine-free phospholipid dispersions and liposomes (Fig. 2-8). In addition, the effect 
of physical mixture of blank liposomes and caffeine solution (caffeine-spiked liposomes) (Fig. 
2-9) and caffeine-entrapped liposomes (caffeine presented only in the liposomes) (Fig. 2-10) 
were determined. Pretreatment with DLPC and DPPG dispersions enhanced the skin 
permeation of caffeine, indicating that these phospholipids had skin penetration-enhancing 
effects, since they might mix and fuse with the SC lipids (like ceramides) to reduce the SC 
barrier function made by well-packed intercellular lipids and create a permeation pathway for 
drugs61,72,73). Interestingly, the pretreatment of caffeine-free liposomes provided lower ER than 
their corresponding phospholipid dispersions.  This could be due to the presence of such 
vesicles having less fluidity to disrupt the rigid structure of SC than its dispersion forms. 
Obviously, only the pretreatment with caffeine-free DPPG liposomes increased the skin 
permeation of caffeine. For the physical mixture of blank liposomes and caffeine, caffeine-
spiked DPPG liposomes could deliver the drug through skin with the highest ER. Caffeine-free 
DPPG liposomes might disrupt the SC structure, allowing the free caffeine being mixed outside 
the liposome vesicles to diffuse through the skin barrier. In consequence, the caffeine-
entrapped DPPG liposomes also provided the highest ER compared to the caffeine-entrapped 
DLPC and DSPG liposomes (Fig. 2-10).  
The highest skin penetration-enhancing effect observed from DPPG liposomes was thus 
due to the synergistic of different actions; the skin penetration-enhancing effect of DPPG 
dispersions and the skin-penetration enhancing effect of caffeine-free DPPG liposomes as well 
as the penetration-enhancing ability of caffeine both outside (caffeine-spiked liposome) and 
inside (caffeine-entrapped liposome) of liposomal vesicles. As similar to the previous report74), 
the penetration of non-entrapped and entrapped hydrophilic fluorescence probe, 
carboxyfluorescein, in liposomes through human skin were increased compared to control 
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solution. The fluorescent may be penetrated along with intact liposomes or associated with 
liposomal fragment. The skin penetration-enhancing effect of DLPC liposomes was obtained 
in spite of only a low degree, and no skin penetration-enhancing effect was observed for DSPG 
liposomes in all cases. However, DPPG was a very promising candidate to design liposome 
formulations to enhance the drug permeation compared to other phospholipids. 
 
2.5. Chapter conclusion 
 
Our findings exhibited that the vesicle composition of liposomes and niosomes is an 
important factor that should be considered by researchers in this field in order to improve the 
performance of these formulations. Understanding the effect of such factor on the performance 
of liposome and niosome formulations could enable researchers to develop the effective 
formulations to improve the skin permeation of drugs. 
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Conclusion 
 
The following conclusion can be obtained from the present results: 
 
(1) SCLLs could be used as a model membrane instead of hairless rat skin to investigate the 
skin penetration-enhancing effect of CPEs. Fair correlation was observed between increase 
in ER and FL leakage/ SCLLs membrane fluidity when using ethanol as a model CPE. 
(2) Use of SCLLs could be a promising approach to determine the effect of various kinds of 
CPEs on the SC skin barrier. The relationship between FL leakage and SCLLs membrane 
fluidity could be utilized to identify the possible mechanism of action of CPEs for 
enhancing the skin permeation of drugs. This approach is useful for testing of CPEs in an 
early stage of development of transdermal/topical formulations. 
(3) Selection of vesicle compositions is an important strategy for preparation of vesicular 
carriers aimed to enhance skin permeation of hydrophilic model drug. Understanding the 
effect of such factors could enable researchers to develop vesicular carriers that intended 
to improve the skin permeation of drugs. 
 
These results obtained in the present study strongly suggested that SCLLs could be used 
as a model skin membrane. In addition, the composition of vesicles must be considered as an 
optimized parameter for enhancing the skin penetration of drugs. 
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